A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Clinical trial NCT04226989 · UNKNOWN

Trial details

NCT number: NCT04226989
Sponsor: He Huang
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma

Start date: 2020-02-05
Primary completion: 2022-02-05
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.